| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial. | Lancet Neurol | 2020 | 3.93 |
| 2 | [Clinical features of NMO according to brain MRI findings]. | Brain Nerve | 2010 | 0.75 |
| 3 | Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature. | Clin Neurol Neurosurg | 2014 | 0.75 |